… of erlotinib with HSA using fluorescence UV–Vis and circular dichroism (CD) spectroscopy
to understand the carrier role of serum albumin for such compounds in blood under …

… Human serum albumin (HSA) is the most abundant plasma protein with a concentration of
∼… ions, but also for a variety of pharmaceutical compounds. HSA is a single chain globular …

… Human serum albumin (HSA) is a globular and monomeric protein in plasma that transport
many drugs … Human serum albumin (HSA) and Erlotinib hydrochloride were prepared from …

… serum albumin (HSA) and considerable stability, has been used to replace human serum
albumin in protein- drug … Since the binding ability of a drug to serum albumin may have an …

… delivery in blood. Therefore, we aim to study BSA interaction with erlotinib as an anticancer
drug … Heart-shaped structure of bovine serum albumin (BSA) is very similar to human serum …

… Aim of this study was to prepare the hyaluronic acid and human serum albumin modified
erlotinib nanoparticles (ERT-HSA-HA NPs) delivery system by a precipitation method. …

… Cytotoxicity assays after 72 h revealed the potential of ANPs to improve erlotinib toxicity (54%
against 34% of free drug toward ASPC-1 cell line, and 52% … Structure of serum albumin …

… , pharmacodynamics, and toxicity of drugs [2]. The two most common serum albumin used
as model transport proteins are BSA and HSA (human serum albumin). There is almost 75.6% …

… or molecular predictors of response to erlotinib have been validated. The … serum albumin
with outcomes in a large cohort of patients with advanced-stage NSCLC treated with erlotinib. …

… site-selective binding of erlotinib hydrochloride (ET), a targeted anticancer drug, to bovine
… Interaction of 4-dimethylaminochalcones with bovine and human serum albumin: A UV–vis …